Abstract
Ocrelizumab (Ocrevus) is now approved by the Food and Drug Administration (FDA) to treat adults with relapsing or primary progressive forms of multipl......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
